Home Pilots Biofourmis reaches unicorn status with $300M Series D Pilots Biofourmis reaches unicorn status with $300M Series D By - April 26, 2022 33 0 Facebook Twitter Pinterest WhatsApp Coming nearly two years after the company’s $100 million Series C, Biofourmis tallied its total raise at $445 million. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES MIT, Movano Health will study long COVID, chronic Lyme disease with Evie Ring Pilots - June 11, 2024 0 Salesforce launches healthcare data platform Einstein Copilot: Health Actions Pilots - March 7, 2024 0 Talkspace, Bicycle Health partner to expand therapeutic offerings Pilots - February 1, 2024 0 Rehab robot maker RoboCT snaps up $15M in Series A+ funding Pilots - April 13, 2022 0 Butterfly Network receives FDA 510(k) for AI-enabled lung tool Pilots - April 10, 2023 0 POPULAR CATEGORIESPilots2166Applications682Testing237Collaborations15GitHub3